Each year, respiratory syncytial virus hospitalizes 58,000 to 80,000 children under age 5 in the U.S. The Food and Drug Administration recently approved an antibody injection for babies to protect them during the RSV season. There isn’t evidence the shots have killed any babies, contrary to social media claims.